Krishna Kanumuri

Sai Life Sciences reported Q2 FY27 revenue of ₹659 crore, a 23% YoY increase, with an EBITDA margin of 28%. The company incurred a capex of ₹621 crore in H1 FY27 and is on track for its full-year proj

Sai Life Sciences reported Q2 FY27 revenue growth of 23% YoY to ₹659 crore with EBITDA margin sustained at 28%. The company invested ₹621 crore in H1 FY27 capacity expansion as part of its ongoing str